Aspirin may boost immune response against cancer cells

Researchers at the University of Cambridge have found that aspirin may help the immune system fight cancer by reducing platelet activity. This could allow T cells to better identify and destroy cancer cells, potentially preventing metastasis. The study, published in the journal Nature, showed that aspirin enhances T cell function in animal models. However, experts caution that more research is needed before making clinical recommendations, as the findings are still in early stages. While aspirin is a well-known medication, its use as a cancer treatment requires further investigation. Current data suggests it may be beneficial for certain cancer types, but it should only be considered under medical supervision or in clinical trials.